The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection

Name: The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection
License: Public Domain

National Institute of Allergy and Infectious Diseases (NIAID)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

acquired-immunodeficiency-syndrome combination drug-therapy hiv-infections t-lymphocytes

hiv infections, t-lymphocytes, polyethylene glycols, interleukin-2, drug therapy, combination, adjuvants, immunologic, acquired immunodeficiency syndrome, zidovudine, thymosin alpha(1), interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

The Safety and Effectiveness of a Type of Interleukin-2 Plus Zidovudine Plus Thymosin in HIV-Positive Patients With and Without Symptoms of Infection

Related documents